The use of processed electroencephalography (pEEG) in obstetric anaesthesia: a narrative review. (May 2023)

• Record Type: Journal Article
• Authors: Corner, H.; Barley, M.; Metodiev, Y.
• Is Part Of: International journal of obstetric anesthesia. Volume 54(2023)
• Publication Date: 2023-05
• Subjects: Caesarean delivery -- Depth of anaesthesia monitoring -- General anaesthesia -- Obstetric anaesthesia -- Processed electroencephalography; Obstetrics -- Periodicals; Anesthesia -- Periodicals; Anesthésie en obstétrique -- Périodiques; Anesthesia; Obstetrics; Electronic journals; Periodicals; 617.9682
• DOI: 10.1016/j.ijoa.2023.103650
• Languages: English
• ISSNs: 0959-289X

Abstract

Highlights: Processed electroencephalogram (EEG) monitoring may reduce awareness. More robust evidence supporting its use during caesarean delivery is required. Processed EEG waveforms may differ between pregnant and non-pregnant patients. Use may provide additional benefits beyond awareness prevention. Abstract: Accidental awareness under general anaesthesia (AAGA) remains a major complication of anaesthesia. The incidence of AAGA during obstetric anaesthesia is high relative to other specialities. The use of processed electroencephalography (pEEG) in the form of "depth of anaesthesia" monitoring has been shown to reduce the incidence of AAGA in the non-obstetric population. The evidence for using pEEG to prevent AAGA in the obstetric population is poor and requires further exploration. Furthermore, pregnancy and disease states affecting the central nervous system, such as pre-eclampsia, may alter the interpretation of pEEG waveforms although this has not been fully characterised. National guidelines exist for pEEG monitoring with total intravenous anaesthesia and for "high-risk" cases regardless of technique, including the obstetric population. However, none of the currently available guidelines relates specifically to obstetric anaesthesia. Using pEEG monitoring for obstetric anaesthesia may also provide additional benefits beyond a reduction in risk of AAGA. These potential benefits include reduced postoperative nausea and vomiting, reduced anaesthetic agent use, and a shorter post-anaesthetic recovery stay. In addition, pEEG acts as a surrogate marker of cerebral perfusion, and thus as an additional monitor for impending cardiovascular collapse, as seen in amniotic fluid embolism. The subtle physiological and pathological changes in EEG activity that may occur during pregnancy are an unexplored research area in the context of anaesthetic pEEG monitors. We believe that the direction of clinical practice is moving towards greater use of pEEG monitoring and individualisation of anaesthesia.